Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients. [electronic resource] by
- Kong, Yaxian
- Zhu, Liuluan
- Schell, Todd D
- Zhang, Jianhong
- Claxton, David F
- Ehmann, W Christopher
- Rybka, Witold B
- George, Melissa R
- Zeng, Hui
- Zheng, Hong
Producer: 20180131
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|
|
|
9.
|
Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients. [electronic resource] by
- Jia, Bei
- Wang, Liru
- Claxton, David F
- Ehmann, W Christopher
- Rybka, Witold B
- Mineishi, Shin
- Rizvi, Syed
- Shike, Hiroko
- Bayerl, Michael
- Schell, Todd D
- Hohl, Raymond J
- Zheng, Hong
Producer: 20190321
In:
Blood cancer journal vol. 8
Availability: No items available.
|
|
|
10.
|
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML. [electronic resource] by
- Wang, Liru
- Jia, Bei
- Claxton, David F
- Ehmann, W Christopher
- Rybka, Witold B
- Mineishi, Shin
- Naik, Seema
- Khawaja, Muhammad R
- Sivik, Jeff
- Han, Junyan
- Hohl, Raymond J
- Zheng, Hong
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 7
Availability: No items available.
|
|
|
11.
|
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma. [electronic resource] by
- Wagner-Johnston, Nina D
- Goy, Andrè
- Rodriguez, Maria A
- Ehmann, W Christopher
- Hamlin, Paul A
- Radford, John
- Thieblemont, Catherine
- Suh, Cheolwon
- Sweetenham, John
- Huang, Yifan
- Sullivan, Sharon T
- Vandendries, Erik R
- Gisselbrecht, Christian
Producer: 20160909
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
|
12.
|
Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML. [electronic resource] by
- Zhao, Chenchen
- Jia, Bei
- Wang, Ming
- Schell, Todd D
- Claxton, David F
- Ehmann, W Christopher
- Rybka, Witold B
- Mineishi, Shin
- Naik, Seema
- Songdej, Natthapol
- Sivik, Jeff M
- Hohl, Raymond J
- Zeng, Hui
- Zheng, Hong
Producer: 20201013
In:
British journal of haematology vol. 188
Availability: No items available.
|
|
|
13.
|
Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia. [electronic resource] by
- Zhu, Liuluan
- Kong, Yaxian
- Zhang, Jianhong
- Claxton, David F
- Ehmann, W Christopher
- Rybka, Witold B
- Palmisiano, Neil D
- Wang, Ming
- Jia, Bei
- Bayerl, Michael
- Schell, Todd D
- Hohl, Raymond J
- Zeng, Hui
- Zheng, Hong
Producer: 20180109
In:
Journal of hematology & oncology vol. 10
Availability: No items available.
|
|
|
14.
|
Eomes [electronic resource] by
- Jia, Bei
- Zhao, Chenchen
- Rakszawski, Kevin L
- Claxton, David F
- Ehmann, W Christopher
- Rybka, Witold B
- Mineishi, Shin
- Wang, Ming
- Shike, Hiroko
- Bayerl, Michael G
- Sivik, Jeffrey M
- Schell, Todd D
- Drabick, Joseph J
- Hohl, Raymond J
- Zheng, Hong
Producer: 20191231
In:
Cancer research vol. 79
Availability: No items available.
|
|
|
15.
|
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia. [electronic resource] by
- Feldman, Eric J
- Brandwein, Joseph
- Stone, Richard
- Kalaycio, Matt
- Moore, Joseph
- O'Connor, Julie
- Wedel, Nancy
- Roboz, Gail J
- Miller, Carole
- Chopra, Raj
- Jurcic, Joseph C
- Brown, Randy
- Ehmann, W Christopher
- Schulman, Philip
- Frankel, Stanley R
- De Angelo, Daniel
- Scheinberg, David
Producer: 20050804
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23
Availability: No items available.
|
|
|
16.
|
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. [electronic resource] by
- Williams, Michael E
- Hong, Fangxin
- Gascoyne, Randy D
- Wagner, Lynne I
- Krauss, John C
- Habermann, Thomas M
- Swinnen, Lode J
- Schuster, Stephen J
- Peterson, Christopher G
- Sborov, Mark D
- Martin, S Eric
- Weiss, Matthias
- Ehmann, W Christopher
- Horning, Sandra J
- Kahl, Brad S
Producer: 20170428
In:
British journal of haematology vol. 173
Availability: No items available.
|
|
|
17.
|
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402. [electronic resource] by
- Kahl, Brad S
- Hong, Fangxin
- Williams, Michael E
- Gascoyne, Randy D
- Wagner, Lynne I
- Krauss, John C
- Habermann, Thomas M
- Swinnen, Lode J
- Schuster, Stephen J
- Peterson, Christopher G
- Sborov, Mark D
- Martin, S Eric
- Weiss, Matthias
- Ehmann, W Christopher
- Horning, Sandra J
Producer: 20141208
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|
|
|
18.
|
PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features. [electronic resource] by
- Teye, Emmanuel K
- Sido, Abigail
- Xin, Ping
- Finnberg, Niklas K
- Gokare, Prashanth
- Kawasawa, Yuka I
- Salzberg, Anna C
- Shimko, Sara
- Bayerl, Michael
- Ehmann, W Christopher
- Claxton, David F
- Rybka, Witold B
- Drabick, Joseph J
- Wang, Hong-Gang
- Abraham, Thomas
- El-Deiry, Wafik S
- Brodsky, Robert A
- J Hohl, Raymond
- Pu, Jeffrey J
Producer: 20180305
In:
Oncotarget vol. 8
Availability: No items available.
|